<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the healthy adult brain, neurogenesis normally occurs in the subventricular zone (SVZ) and hippocampal dentate gyrus (DG) </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> enhances neurogenesis in neurogenic and non-neurogenic regions of the ischemic brain of adult rodents </plain></SENT>
<SENT sid="2" pm="."><plain>This study demonstrated that post-insult treatment with a <z:chebi fb="0" ids="15358">histone</z:chebi> deacetylase inhibitor, <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="0" ids="17968">butyrate</z:chebi> (SB), stimulated the incorporation of <z:chebi fb="1" ids="22927,47265">bromo</z:chebi>-2'-deoxyuridine (BrdU) in the SVZ, DG, striatum, and frontal cortex in the ischemic brain of rats subjected to permanent <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>SB treatment also increased the number of cells expressing <z:chebi fb="0" ids="26206">polysialic acid</z:chebi>-neural cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule, nestin, glial fibrillary acidic protein, phospho-cAMP response element-binding protein (CREB), and brain-derived neurotrophic factor (BDNF) in various brain regions after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, extensive co-localization of BrdU and <z:chebi fb="0" ids="26206">polysialic acid</z:chebi>-neural cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule was observed in multiple regions after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and SB treatment up-regulated protein levels of BDNF, phospho-CREB, and glial fibrillary acidic protein </plain></SENT>
<SENT sid="5" pm="."><plain>Intraventricular injection of K252a, a tyrosine kinase B receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, markedly reduced SB-induced cell proliferation detected by BrdU and Ki67 in the ipsilateral SVZ, DG, and other brain regions, blocked SB-induced nestin expression and CREB activation, and attenuated the long-lasting behavioral benefits of SB </plain></SENT>
<SENT sid="6" pm="."><plain>Together, these results suggest that <z:chebi fb="0" ids="15358">histone</z:chebi> deacetylase inhibitor-induced cell proliferation, migration and differentiation require BDNF-tyrosine kinase B signaling and may contribute to long-term beneficial effects of SB after ischemic injury </plain></SENT>
</text></document>